MirimGENE Selected as an Official Nominee for Best Startup at Prix Galien Korea 2026
November 17, 2026
MirimGENE has been selected as an official nominee in the Best Startup category at Prix Galien Korea 2026. The Prix Galien is an internationally recognized awards program honoring outstanding innovations in medicines and medical technologies that contribute to improving human health. Held in Korea for the first time in 2026, the program recognized MirimGENE as an official n...
READ MORE >